ArticleMaterials today. Bio2025
Integrated bioprinting of trachea-like structures based on tissue-specific bioink.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- DLP bioprinting of cartilage organoid-laden bioinks yields high-fidelity auricular constructs with enhanced chondrogenesis.Stem cell research & therapy · 2026Article
- Bioprinting in Tissue Repair and Its ENT Applications.Polymers · 2026Review
- Towards a bioengineered airway: advances in tracheal tissue engineering and biofabrication.Frontiers in cell and developmental biology · 2026Review
- Current status, trend and progress of stem cells in tracheal tissue engineering research: an overview and perspectives.Stem cell research & therapy · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Segmental tracheal reconstruction remains clinically challenging due to insufficient blood supply and mechanical instability in current graft materials. Inspired by the natural trachea's alternating cartilage-fiber structure, we developed a 3D-bioprinted chondro-fibrous integrated trachea (CFT) using customized tissue-specific hydrogels modified with glucomannan-peptide copolymer (GM-P). This design mimics the native tissue's layered organization, combining cartilage-like rings (from iPSC-derived chondrocytes) and fibrous connective layers (from fibroblasts) through precise bioprinting. The GM-P hydrogel improved interlayer bonding and supported vascularization. Furthermore, in vivo trachea regeneration in nude mice showed satisfactory mechanical adaptability and efficient physiological regeneration. Finally, in situ segmental trachea reconstruction by direct end-to-end anastomosis in rabbits was successfully achieved without collapse. Altogether, this study combines layered bioprinting, tissue-specific multifunctional hydrogel, and stem cell technology, providing a technical reference for construction of complex tissues and promotes the clinical translation and application of engineered tissues or organs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.